EC Number |
Inhibitors |
Structure |
---|
3.4.24.85 | (2E)-N-(2-[[3-(3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-8-yl)propyl]sulfanyl]phenyl)-3-phenylprop-2-enamide |
- |
|
3.4.24.85 | 1,10-phenanthroline |
- |
|
3.4.24.85 | 1-[(benzoylamino)methyl]-1-[3-(benzylsulfanyl)-1-methoxy-1-oxopropan-2-yl]-4-[(benzylsulfanyl)methyl]-2,5-dioxoimidazolidin-1-ium |
- |
|
3.4.24.85 | 3-(butan-2-yl)-8-[3-[(4-fluorophenyl)sulfanyl]propyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one |
- |
|
3.4.24.85 | 7,8-dimethoxy-1,2,3,11a-tetrahydro-5H,11H-pyrrolo[2,1-c][1,4]benzothiazepine-5,11-dione |
- |
|
3.4.24.85 | BofA protein |
- |
|
3.4.24.85 | methyl 4-[[4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-oxobutyl]sulfanyl]benzoate |
- |
|
3.4.24.85 | 1,10-phenanthroline |
1,10-phenanthroline specifically inhibits substrate cleavage in a concentration-dependent manner |
|
3.4.24.85 | 7,8-dimethoxy-1,2,3,11a-tetrahydro-5H,11H-pyrrolo[2,1-c][1,4]benzothiazepine-5,11-dione |
analog of nelfinavir, inhibits cleavage of artificial protein substrate CED-9 in an in vitro proteolysis assay. Inhibits castration-resistant prostate cancer proliferation by blocking regulated intramembrane proteolysis through suppression of site-2 protease cleavage activity |
|
3.4.24.85 | more |
gamma-sectretase inhibitor LY411575 is not inhibitory for enzyme |
|